Downloads: 125

Files in This Item:
File Description SizeFormat 
24_0257.pdf776.87 kBAdobe PDFView/Open
Title: 前立腺肥大症に対するGestonorone Caproate(SH582)の臨床効果
Other Titles: CLINICAL EFFECTS OF GESTONORONE CAPROATE ON BENIGN PROSTATIC HYPERTROPHY
Authors: 森岡, 政明  KAKEN_name
赤枝, 輝明  KAKEN_name
大橋, 輝久  KAKEN_name
松村, 陽右  KAKEN_name
大森, 弘之  KAKEN_name
高田, 元敬  KAKEN_name
Author's alias: Morioka, Masaaki
Akaeda, Teruaki
Ohashi, Teruhisa
Matsumura, Yosuke
Oomori, Hiroyuki
Takata, Motoyoshi
Issue Date: Mar-1978
Publisher: 京都大学医学部泌尿器科学教室
Journal title: 泌尿器科紀要
Volume: 24
Issue: 3
Start page: 257
End page: 260
Abstract: Seventeen patients with benign prostatic hypertrophy (BPH) were treated with a new progestational agent, Gestonorone caproate (SH 582). 200 mg of SH 582 was injected intramuscularly at weekly intervals for 4-24 weeks. Clinical evaluations on subjective and objective findings were examined in 16 cases observed for 8-24 weeks. The improvement of subjective symptoms and objective findings was noted in 10 cases (62.5%) and in 6 cases (37.5%) respectively. Abnormal changes of laboratory data were not observed in all cases after injection of SH 582. Therefore, SH 582 seemed to be effective in cases of early staged BPH in order to improve subjective symptoms.
URI: http://hdl.handle.net/2433/122183
Appears in Collections:Vol.24 No.3

Show full item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.